Search Results - "Merry, Audrey H. H."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Risk prediction of incident coronary heart disease in the Netherlands: re-estimation and improvement of the SCORE risk function by Merry, Audrey HH, Boer, Jolanda MA, Schouten, Leo J, Ambergen, Ton, Steyerberg, Ewout W, Feskens, Edith JM, Verschuren, WM Monique, Gorgels, Anton PM, van den Brandt, Piet A

    Published in European journal of preventive cardiology (01-08-2012)
    “…Aims: To re-estimate the SCORE risk function using individual data on risk factors and coronary heart disease (CHD) incidence from the Dutch Cardiovascular…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Co-occurrence of metabolic factors and the risk of coronary heart disease: A prospective cohort study in the Netherlands by Merry, Audrey H.H, Erkens, Petra M.G, Boer, Jolanda M.A, Schouten, Leo J, Feskens, Edith J.M, Verschuren, W.M. Monique, Gorgels, Anton P.M, van den Brandt, Piet A

    Published in International journal of cardiology (08-03-2012)
    “…Abstract Background Prevalence of metabolic factors such as diabetes, hypertension, obesity, HDL and total cholesterol that are associated with an increased…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study by Merry, Audrey H H, Schouten, Leo J, Goldbohm, R Alexandra, van den Brandt, Piet A

    Published in Gut (01-11-2007)
    “…Background:In the last decades, the incidence of oesophageal and gastric cardia adenocarcinoma has increased rapidly in the Western world. We investigated the…”
    Get full text
    Journal Article
  10. 10

    Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg by Teunissen, Anna M., Merry, Audrey H. H., Devies, Ingrid E. C., Roumen, Frans J. M. E.

    “…Objective: To investigate differences in continuation rates between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13